Table 3 Distribution of bacterial etiologies, predisposing factors and outcomes among patients with IE at the KUH

All patients, n (%)

92 (19)

156 (32)

83 (17)

139 (28)

33 (7)

Staphylococcus aureus

28 (30), 0.39, 0.23–0.65; < 0.01

122 (78), 6.72, 4.24–10.76; < 0.01

36 (43), 0.78, 0.47–1.28; 0.30

61 (44), 0.77, 0.51–1.16; 0.19

21 (64), 1.93, 0.88–4.42; 0.07

CoNS

8 (9), 2.29, 0.82–5.88; 0.06

2 (1), 0.19, 0.02–0.77; 0.01

11 (13), 4.65, 1.80–11.71; < 0.01

10 (7), 1.88, 0.73–4.67; 0.13

2 (6), 1.28, 0.14–5.62; 0.67

Viridans group streptococci

14 (15), 0.64, 0.32–1.20; 0.15

8 (5), 0.14, 0.06–0.30; < 0.01

14 (17), 0.74, 0.37–1.41; 0.34

34 (24), 1.36, 0.82–2.22; 0.20

6 (18), 0.84, 0.28–2.16; 0.71

Group B streptococci

1 (1), 0.43, 0.01–3.09; 0.70

0 (0)

2 (2), 1.10, 0.11–5.44; 1.00

3 (2), 0.95, 0.16–4.04; 1.00

1 (3), 1.38, 0.04–10.22;0.54

Group D streptococci

3 (3), 3.34, 0.48–20.04; 0.13

0 (0)

1 (1), 0.82, 0.02–6.89; 1.00

4 (3), 3.46, 0.57–23.84; 0.10

0 (0)

Group G streptococci

2 (2), 1.46, 0.14–8.33; 0.65

1 (1), 0.30, 0.01–2.40; 0.45

0 (0)

1 (1), 0.36, 0.01–2.83; 0.45

0 (0)

Enterococcus faecalis

17 (18), 2.52, 1.25–4.93; < 0.01

17 (11), 1.12, 0.57–2.16; 0.71

11 (13), 1.45, 0.64–3.05; 0.31

9 (6), 0.53, 0.22–1.14; 0.09

2 (6), 0.55, 0.06–2.29; 0.56

HACEK

5 (5), 2.24, 0.58–7.39; 0.17

0 (0)

4 (5), 1.83, 0.41–6.38; 0.30

8 (6), 3.02, 0.93–9.96; 0.03

1 (3), 0.99, 0.03–6.94; 1.00